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To examine the genetic control of acute and late disease induced by a murine coronavirus, strain JHM (JHMV), BALB/cHeA, STS/A, F, hybrids and 13 recombinant inbred (RI) strains between BALBlcHeA and STS/A mouse strains were inoculated intracerebrally with 100 pfu of JHMV. All the BALB/cHeA mice died within 2 weeks from acute encephalitis. In contrast, STS/A mice were shown to be partially resistant, with a mortality rate of 30%, longer survival times and lower rates of viral production.
The mortality rates, survival times and viral titers of F, hybrids and the RI strains varied, suggesting involvement of multiple genes. STS/A, F, hybrid and RI mice surviving the acute infection occasionally developed severe paraparesis about 1 month post-infection.
In these mice, vacuolar degeneration, astrocytosis, the absence of perivascular cuffing and minimal demyelination were found in the central nervous system. No infectious virus could be recovered from these mice. Although the paralysis of delayed onset was limited to STS/A, F, hybrid and eight of the 13 RI strains, the incidence varied significantly among the RI strains. These results may suggest that JHMV-induced late disease is also under multifactorial control. The pathogenesis of JHMV infection is discussed. induce demyelination but not fatal encephalomyelitis.
One variant, designated JHM-cc," isolated from DBT cells persistently infected with JHM-x, induces vacuolar degeneration.13 We attempted to analyse the genetic control of the acute and late diseases after infection with a low dose of JHMV using BALB/cHeA, STS/A, F, hybrid and 13 RI strains between BALB/cHeA and STS/A mouse strains,14 since the two parent strains of mice show different pathogenesis after i.c. infection.
Results

JHMV-induced acute disease
Female, 6-8-week-old mice of BALB/cHeA, STS/A, F, hybrid and RI strains were inoculated i.c. with 100 pfu of JH MV and monitored for acute disease for 2 weeks. A total of 588 mice were used in 21 experiments. The cumulative results of these experiments are summarized in Table 1 . After i.c. infection with 100 pfu of JHMV, all mice showed signs of mild or severe encephalitis. Following the onset of the clinical signs, 100% of the BALB/cHeA mice and 30% of the STS/A mice died within 2 weeks. Both F, hybrids (BALB/cHeAxSTS/A)F, (CSF,) and (STS/AxBALB/cHeA)F, (SCF,) died with intermediate rates during the acute phase. The mortality of the RI strains varied from 72-l 00%. Interestingly, two RI strains (CXSG and CXS14) exhibited high mortality similar to the BALB/cHeA parental strain. STS/A mice were also less susceptible than BALB/cHeA mice with respect to survival times.
Virus titers in the brains from all strains were assayed on day 5 post-infection (p.i.), when virus titer peaks in both BALB/cHeA and STS/A mice. Although the difference in viral titers was limited among the strains tested, a lower rate of viral growth was observed in STS/A mice compared to BALB/cHeA mice. There was a slight positive correlation between the mortality and the viral titer (r = 0.42). There was also a slight negative correlation between survival times and the viral titers (r = 0.53).
Two each of BALB/cHeA, STS/A and both F, hybrid mice were sacrificed on day 5 p.i. for histological examinations. lmmunoperoxidase staining revealed abundant viral antigens in the brains and spinal cords of BALB/cHeA mice [ Fig. 1 (a) ]. In STS/A mice, less viral antigens were detected; however, the inflammatory response, especially perivascular cuffing, was more prominent than BALB/cHeA mice [ Fig. 1 (b) ].
JHMV-induced late disease
The animals that survived acute infection were monitored for late disease till 2 months p.i. ( Table 2 ). All of the STS/A mice that had survived acute infection recovered clinically by 3 or 4 weeks p.i. Subsequently, one-third of the STS/A survivors began to show severe hind leg paralysis beginning about 1 month p.i., and then died by 2 months p.i. Some of the F, hybrids and of some RI strains (CXS2, CXS3, CXS4, CXS5, CXS8, CXSll, CXS12 and CXS13) also showed hind leg paralysis. However, the incidence of paralysis varied greatly among the RI strains (8-100%).
In addition, some mice recovered from the paralysis, in contrast to the parent STS/A mice. Mice of CXSI, CXS7 and CXSlO strains showed no evidence of paralysis. Some mice which were clinically normal during the initial 2 months were monitored for an extended period. None of these mice showed evidence of paralysis during this period (data not shown). At various times p.i., we attempted to isolate infectious virus from the brains of surviving mice with various clinical status (Table 3) . Infectious virus could only be isolated from the brains of mice which showed signs of mild encephalitis at day 11 p.i. No infectious virus was recovered from the brains of mice showing paralysis.
The brains and spinal cords of mice showing evidence of paralysis were studied histologically.
Vacuolar degeneration was observed in the brainstem and spinal cord [ Fig. 2(a) ]. Astrocytosis was also observed in the lesions [Fig. 2(b) ]. However, there was little infiltration by mononuclear cells. Trace amounts of viral antigens were detected. The degree of demyelination also appeared to be slight. Although the number of samples was limited, no obvious difference in the histopathological changes dependent on mouse strain was observed in mice manifesting paralysis. These histological changes appeared to be distinct from that of mice infected with a JHMV variant (2.2-V-l ) with a major demyelination inducing determinant.15.16
Discussion
Several strains of murine coronavirus have facilitated studies of natural resistance to viral infections. Bang et al. found that a single recessive gene encodes the resistance of PRI mice to mouse hepatitis virus type 2 infection.17 Alternatively, a genetic study indicated that resistance to mouse hepatitis virus type 3 infection involves at least two major genes: one for the acute disease and the other, H-2-linked, for the chronic disease.'* The genetic resistance to JHMV infection has also been studied by several groups but remains controversial.
Stohlman et al. found that only SJL/J mice are resistant to acute fatal JHMV infection among 19 strains tested3," and suggest that two genes are involved in the resistance to acute fatal JHMV infection3 However, using a lower dose of virus, Knobler et a/. suggest that a single gene controls the resistance to acute JHMV infection in SJL/J mice.4 Furthermore, the mechanism of the resistance seems to be discrepant. Although Wilson and Dales find no critical difference in the early events from adsorption to genome activation between JHMVresistant SJL/J and JHMV-susceptible CD.1 glial cultures," Holmes and colleagues have proposed that the resistance of SJL/J mice is perhaps due to the lack of functional virus receptor on the plasma membrane.*'
To examine the genetic control of diseases induce by the JHMV strain maintained in this laboratory, some preliminary experiments were performed. As reported earlier,3,4 BALB/cHeA, C57BL/6, C57BL/lO and DBA/2 mice died due to acute encephaiitis after i.c. infection with 100 pfu of JHMV. However, 30% of STS/A and 100% of SJL/J mice survived the acute phase of infection. In addition, some survivors of the STS/A strain subsequently manifested hind leg paralysis (data not shown). Due to the availability of RI strains between the BALB/cHeA and STS/A strains,14 we chose these parent strains to carry out genetic analysis of JHMV-induced disease. Although the number of mice tested was not large enough to make this conclusion, the large variation in the incidence of paralysis among RI strains might suggest that paralytic disease is also inherited as a multiple trait. Our data suggest that JHMV-induced acute and late disease is inherited as a multiple trait. Nonetheless, differential incidence of gene expression, possibly due to environmental influences and variable penetrance of the gene, cannot be ruled out. Therefore, it may be worth analysing the genetics of JHMV-induced disease using the hypothesis that a single gene, or one major gene, controls the disease. We have tentatively designated the gene as Pj-1 and divided the mouse strains into the strains showing sublethal infection with paralysis of delayed onset, represented by STS/A mice, and the strains inducing fatal encephalitis, represented by BALB/cHeA mice. Mice exhibiting more than a 30% incidence were considered to constitute a STS/A type strain. The mouse strain which died from acute encephalitis was considered to constitute a BALB/cHeA type. Comparing with the strain distribution pattern (SDP) of 92 genes which have determined thus far, we found a good correlation between the SDP of the Pj-1 and the SDP of some markers on mouse chromosome 7 (Table  4 ). Since no recombinant was observed between the Pj-1 and Ly-15, the Pj-1 gene may be located near the Ly-15 locus. The Ly-15 encodes one of immunologically important molecules known as lymphocyte function-associated antigen-l (LFA-1 ).33 LFA-1 is believed to bind to ICAM-I and facilitate T cell recognition. In fact, Davignon et al. have shown that this molecule is involved in cytotoxic T cell response,34 which is believed to be a major effector mechanism in JHMV clearance from the brain. 35, 36 Since infection of neurons resulting in a necrotizing fatal encephalomyelitis is a major cause of death due to JHMV infection, it is possible that this molecule is involved, not only in the prevention of death by limiting virus replication, but also in the development of late disease.
Finally, STS/A mice was semi-resistant to JHMV and showed a biphasic CNS disease following JHMV infection. The same phenomenon was reported in mouse hepatitis type 3 infection.18 Semi-susceptibility of the host seems to be necessary for the development of late disease. This may suggest that host's antiviral response(s) not only protect mice from a necrotizing encephalitis but also trigger late disease. Alternatively, increased incidence of late disease was observed following transfer of partial immunity to JHMV.37 Taken together, JHMV-induced late disease may occur under a subtle balance between the virus and the immune system. Polygenic inheritance may be suitable to interpret such a complex situation.
Materials and methods
Mice. BALB/cHeA, STSIA. CSF,, SCF, and 13 RI strains between BALB/cHeA and STS/A'4 were bred and maintained in our laboratory. The breeding colonies were kept in a lamina flow- 
